成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

LangFangshi Zekang Pharma Tech CO.,Itd.

Firmenname:LangFangshi Zekang Pharma Tech CO.,Itd.
Telefon:0316-2883536
E-Mail:1877241811@qq.com
Nationalit?t:China
URL: www.is0513.com/showsupplierproductslist1466071/0.htm
Produkte insgesamt:1437
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Produktkatalog

INDEX NAME NOT YET ASSIGNED2749405-42-1C16H13BrN6O2
Imatinib Impurity 11404844-11-7C24H20ClN5O
3-AMINO-3-(4-BROMOPHENYL)ACRYLONITRILE748807-82-1C9H7BrN2
3-(4-fluorophenyl)-3-oxopropanamide671188-82-2C9H8FNO2
4-Chlorobenzoylacetonitrile4640-66-8C9H6ClNO
Cycloocta[b]pyridine, 2-(4-ethyl-1-piperazinyl)-5,6,7,8,9,10-hexahydro-4-phenyl-132810-75-4C23H31N3
Linagliptin Impurity S668273-74-3C30H36N8O4
Mometasone105102-22-5C22H28Cl2O4
Diethyl 2-(2-chloroethyl)propanedioate18719-42-1C9H15ClO4
6-Chloro-1H-cinnolin-4-one876-89-1C8H5ClN2O
N1-ethyl-N2-(4-(4-fluorophenyl)-5,6,7,8,9,10-hexahydrocycloocta[b]pyridin-2-yl)ethane-1,2-diamine hydrochloride2243798-59-4C21H28FN3
Ethanone, 1,1'-cyclobutylidenebis-126290-88-8C8H12O2
Cycloocta[b]pyridine, 2-chloro-4-(3-fluorophenyl)-5,6,7,8,9,10-hexahydro-132813-15-1C17H17ClFN
N1,N3-bis(4-fluorophenyl)malonamide(CabozantinibImpurity）1677-29-8C15H12F2N2O2
2-Chloro-4-(4-fluorophenyl)-5，6，7，8，9，10-hexahydrocycloocta[b]pyridine132813-14-0C17H17ClFN
Cabozantinib impurity 512354-89-4C10H10FNO
Blonanserin Impurity I49860-76-6C7H16N2
Cabozantinib Impurity495932-39-1C11H15NO3
Cabozantinib impurity 47113136-79-1C11H10ClNO3
Cabozantinib Impurity 8918642-61-2C11H10FNO3
Cabozantinib Impurity 61621681-63-7C28H24FN3O6
Cabozantinib Impurity 102439164-91-5C39H34N4O8
tert-butyl (R)-(1-((4-methylquinazolin-2-yl)methyl)piperidin-3-yl)carbamate2514949-81-4C20H28N4O2
Cycloocta[b]pyridin-2-amine, 4-(4-fluorophenyl)-5,6,7,8,9,10-hexahydro-2518376-10-6C17H19FN2
Formamide, N-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-190728-28-0C18H16N2O4
1-(phenylaminocarbonyl)cyclopropanecarboxylicacid145591-80-6C11H11NO3
Linagliptin Impurity 241418133-47-7C50H56N16O4
Quinoline, 6,7-dimethoxy-4-(4-nitrophenoxy)-190728-24-6C17H14N2O5
Cycloocta[b]pyridine, 4-(4-fluorophenyl)-5,6,7,8,9,10-hexahydro-2-(1-piperazinyl)-132811-84-8C21H26FN3
Linagliptin Impurity 161791405-13-4C15H20N6O2
N-(4-((6,7-dimethoxyquinolin-4-yl)oxy)phenyl)-N-phenylcyclopropane-1,1-dicarboxamide849221-94-9C28H25N3O5
1,1-Cyclobutanedicarboxylic acidCyclobutan-1,1-dicarbonsure5445-51-2C6H8O4
Blonanserin Impurity K142838-82-2C23H30FN3O
4-(4-Carboxybenzyl)piperazine-1-carboxylic acid tert-butyl ester479353-63-4C17H24N2O4
Linagliptin Impurity 292074688-82-5C58H58N16O6
Imatinib EP Impurity F152460-10-1C16H15N5
Acetamide, N-(2-acetylphenyl)-2,2-dichloro-6140-12-1C10H9Cl2NO2
3-Dimethylamino-1-(N-oxido-4-pyridyl)-2-propen-1-on2387475-37-6C10H12N2O2
Linagliptin Impurity 35668273-75-4C30H36N8O4
2-(4-ethylpiperazin-1-yl)-4-(4-(4-ethylpiperazin-1-yl)phenyl)-5,6,7,8,9,10-hexahydrocycloocta[b]pyridine1648791-23-4C29H43N5
Cabozantinib Impurity 141175127-32-8C12H13NO3
1-Piperazinecarboxaldehyde, 4-ethyl-21863-75-2C7H14N2O
Blonanserin Impurity 181477480-40-2C19H24FN3
Blonanserin Impurity 15132813-16-2C17H17ClFN
2-Propenenitrile, 3-amino-3-(3-fluorophenyl)-71682-85-4C9H7FN2
N-Desmethyl Imatinib404844-02-6C28H29N7O
1,4-Bis-[4-[4-Methyl-3-[[4-(pyridin-3-yl)pyriMidin-2-yl]aMino]phenyl]carbaMoyl]benzylpiperazine1365802-18-1C52H48N12O2
Blonanserin iMpurity132810-83-4C23H30FN3
Desfluoro Hydroxy Blonanserin132812-29-4C23H31N3O
1-((4-((6,7-dimethoxyquinolin-4-yl)oxy)phenyl)carbamoyl)cyclopropane-1-carboxylic acid849217-77-2C22H20N2O6
3-(2-Fluorophenyl)-3-oxopropionitrile31915-26-1C9H6FNO
3-Amino-3-(4-chlorophenyl)prop-2-enenitrile25354-58-9C9H7ClN2
Imatinib Impurity 1914188-94-4C7H7NO2
Diazene, bis(4-fluorophenyl)-, (Z)- (9CI)51789-00-5C12H8F2N2
Benzamide, 4-[[4-[4-[(4-methyl-1-piperazinyl)methyl]benzoyl]-1-piperazinyl]methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-2410195-23-0C41H45N9O2
Cycloocta[b]pyridin-2(1H)-one, 4-(2-fluorophenyl)-5,6,7,8,9,10-hexahydro-132812-74-9C17H18FNO
INDEX NAME NOT YET ASSIGNED2748381-67-9C26H32N8O4
1-((4-Fluorophenyl)carbamoyl)cyclopropanecarboxylicacid849217-48-7C11H10FNO3
4-((6,7-Dimethoxyquinolin-4-yl)oxy)aniline190728-25-7C17H16N2O3
Cabozantinib Impurity 4295262-10-5C9H8FNO3
Cabozantinib Impurity 91431468-36-8C17H14F2N2O2
2-chloro-4-(4-fluorophenyl)-5,6,7,8,9,10-hexahydrocycloocta[b]pyridine 1-oxide143213-96-1C17H17ClFNO
Imatinib EP Impurity C1407124-77-9C21H26ClN2O4+
Imatinib EP Impurity J571186-91-9C29H31N7O2
iMatinib related substance B571186-93-1C29H31N7O3
Mometasone Furoate Impurity O24916-91-4C24H31ClO6
(Z)-3-Amino-3-(4-fluoro-phenyl)-acrylonitrile55330-46-6C9H7FN2
Imatinib Impurity 171802325-93-4C20H22N2O4
6,7-Quinolinediol, 4-chloro-1256637-72-5C9H6ClNO2
Cyclobutanecarboxylic acid, 1-[[(4-fluorophenyl)amino]carbonyl]-849217-49-8C12H12FNO3
Cycloocta[b]pyridine, 2-chloro-4-(4-chlorophenyl)-5,6,7,8,9,10-hexahydro-132813-22-0C17H17Cl2N
(E)-3-AMINO-3-(4-CHLOROPHENYL)-2-PROPENENITRILE;(2E)-3-amino-3-(4-chlorophenyl)prop-2-enenitrile107840-43-7C9H7ClN2
Cabozantinib impurity1904529-45-8C17H14Cl2N2O2
8-Bromo-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione853029-57-9C20H17BrN6O2
Linagliptin iMpurity G668270-11-9C25H28N8O2
Blonanserin Impurity 10132810-87-8C23H30ClN3
Tert-butyl4-(4-(methoxycarbonyl)benzyl)piperazine-1-carboxylate844891-11-8C18H26N2O4
3-Fluorobenzoylacetonitrile21667-61-8C9H6FNO
Cabozantinib Impurity 11861345-47-3C18H18N2O2
N-Depiperidin-3-amine Linagliptin Dimer2253964-98-4C45H44N14O4
3-amino-3-(4-fluorophenyl)propanenitrile1270488-91-9C9H9FN2
4-Fluorobenzoylacetonitrile4640-67-9C9H6FNO
Cycloocta[b]pyridin-2(1H)-one, 5,6,7,8,9,10-hexahydro-4-phenyl-132812-71-6C17H19NO
2-amino-6-methylbenzenecarboximidamide1694987-11-5C8H11N3
2 - (ChloracetylaMino)acetophenon6140-11-0C10H10ClNO2
Cabozantinib impurity 1748707-58-6C17H16N2O3
4-[(E)-(4-hydroxyphenyl)azo]phenol51437-66-2C12H10N2O2
Cabozantinib Impurity 251247859-37-5C11H10FNO3
Linagliptin Impurity A2436762-89-7C14H13BrN4O2
Linagliptin Impurity 452463617-43-6C25H28N8O2
N-(4-Fluorophenyl)-N'-(4-hydroxyphenyl)cyclopropane-1,1-dicarboxamide(CabozantinibImpurity)849217-60-3C17H15FN2O3
Benzenepropanoic acid, 4-fluoro-b-oxo-80646-00-0C9H7FO3
iMatinib related substance C938082-57-6C29H31N7O2
11,17-Difuroate MoMetasone Furoate1370190-33-2C32H32Cl2O8
Linagliptin Impurity 282074688-84-7C22H23N7O3
Cabozantinib Impurity 52377278-36-7C11H10ClNO3
6-Chloro-1-hydroxibenzotriazol26198-19-6C6H4ClN3O
Linagliptin impurity KH-22279114-31-5C20H18BrN5O4
Benzoic acid, 4,4'-[1,4-piperazinediylbis(methylene)]bis-, dimethyl ester (9CI)80276-39-7C22H26N2O4
1H-Purine-2,6-dione, 7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-8-[(4-methyl-2-quinazolinyl)methoxy]-1-[(4-methyl-2-quinazolinyl)methyl]-2469626-53-5C30H26N8O3
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
Copyright 2019 ? ChemicalBook. All rights reserved